1. Blei AT, Cordoba J. Practice Parameters Committee of the American College of Gastroenterology. Hepatic encephalopathy. Am J Gastroenterol. 2001. 96:1968–1976.
Article
2. Kiba T, Numata K, Saito S. Neostigmine and polyethylene glycol electrolyte solution for the therapy of acute hepatic encephalopathy with liver cirrhosis and ascites. Hepatogastroenterology. 2003. 50:823–826.
3. Runyon BA. Fatal bacterial peritonitis secondary to nonobstructive colonic dilatation (Ogilvie's syndrome) in cirrhotic ascites. J Clin Gastroenterol. 1986. 8:687–689.
Article
4. Morgan MY, Hawley KE. Lactitol vs. lactulose in the treatment of acute hepatic encephalopathy in cirrhotic patients: a double-blind, randomized trial. Hepatology. 1987. 7:1278–1284.
Article
5. Strauss E, da Costa MF. The importance of bacterial infections as precipiting factors of chronic hepatic encephalopathy in cirrhosis. Hepatogastroenterology. 1998. 45:900–904.
6. Malbrain ML. Abdominal pressure in the critically ill: measurement and clinical relevance. Intensive Care Med. 1999. 25:1453–1458.
Article
7. Paran H, Silverberg D, Mayo A, Shwartz I, Neufeld D, Freund U. Treatment of acute colonic pseudo-obstruction with neostigmine. J Am Coll Surg. 2000. 190:315–318.
8. Amaro R, Rogers AI. Neostigmine infusion: New standard of care for acute colonic pseudo-obstruction? Am J Gastroenterol. 2000. 95:304–305.
9. Ponec RJ, Saunders MD, Kimmey MB. Neostigmine for the treatment of acute colonic pseudo-obstruction. N Engl J Med. 1999. 341:137–141.
10. Trevisani GT, Hyman NH, Church JM. Neostigmine: safe and effective treatment for acute colonic pseudo-obstruction. Dis Colon Rectum. 2000. 43:599–603.
11. Delgado-Aros S, Camilleri M. Pseudo-obstruction in the critically ill. Best Pract Res Clin Gastroenterol. 2003. 17:427–444.
Article
12. Beck DE, Fazio VW, Jagelman DG. Comparison of oral lavage methods for preoperative colonic cleansing. Dis Colon Rectum. 1986. 29:699–703.
Article